Haemostatic variables in phenylketonuric children under dietary treatment
- PMID: 8892015
- DOI: 10.1007/BF01799833
Haemostatic variables in phenylketonuric children under dietary treatment
Abstract
Classical phenylketonuria (PKU) (McKusick 261600) is an inborn error of metabolism treated by a controlled low-phenylalanine (Phe) diet started as soon as possible in the first days of life. Such a diet can be achieved with vegetable protein and can be considered non-atherogenic because of the reduction of animal products. Thirty patients with PKU were classified into two groups according to their annual mean Phe levels. Their daily protein intake was largely replaced by PKU2 Milupa which contains a mixture of amino acids. The product has no phenylalanine or fat of any kind. Thirty-eight (38) individuals of comparable age were used as controls. Group A (n = 15) had good compliance with the special diet (Phe mean 192 +/- 115 mumol/L); group B (n = 15) did not strictly adhere to the diet (Phe mean 595 +/- 263 mumol/L). Certain haemostatic components (factors I, VII, VIII, and X, antithrombin III, protein C, and plasminogen) and lipid variables (cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein, very-low-density lipoprotein) as well as Phe levels were estimated. All the haemostatic factors studied were found within the normal range with the exception of a significant reduction in protein C in both groups of PKU patients. Furthermore, a statistically significant reduction in factor VII and X concentrations was observed in patients on strict diet. Cholesterol and low-density lipoprotein concentrations were significantly lower in PKU children compared to normal controls. It is suggested that even though the special diet of PKU children, especially in group A, is rich in vegetables, the reduced fat intake might have impaired the absorption of vitamin K and its delivery to the site of synthesis of vitamin K-dependent haemostatic factors.
Similar articles
-
The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.Clin Nutr. 2004 Jun;23(3):401-7. doi: 10.1016/j.clnu.2003.09.006. Clin Nutr. 2004. PMID: 15158304
-
Effect of diet on plasma total antioxidant status in phenylketonuric patients.Eur J Clin Nutr. 2003 Feb;57(2):383-7. doi: 10.1038/sj.ejcn.1601529. Eur J Clin Nutr. 2003. PMID: 12571675
-
Lipid profile status and other related factors in patients with Hyperphenylalaninaemia.Orphanet J Rare Dis. 2016 Sep 9;11(1):123. doi: 10.1186/s13023-016-0508-x. Orphanet J Rare Dis. 2016. PMID: 27612877 Free PMC article.
-
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.Orphanet J Rare Dis. 2019 Feb 15;14(1):44. doi: 10.1186/s13023-019-1011-y. Orphanet J Rare Dis. 2019. PMID: 30770754 Free PMC article. Review.
-
Optimising growth in phenylketonuria: current state of the clinical evidence base.Clin Nutr. 2012 Feb;31(1):16-21. doi: 10.1016/j.clnu.2011.09.001. Epub 2011 Sep 29. Clin Nutr. 2012. PMID: 21959353 Review.
Cited by
-
Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.Orphanet J Rare Dis. 2018 Jun 26;13(1):101. doi: 10.1186/s13023-018-0839-x. Orphanet J Rare Dis. 2018. PMID: 29941009 Free PMC article.
-
Vitamin K Status in Adherent and Non-Adherent Patients with Phenylketonuria: A Cross-Sectional Study.Nutrients. 2020 Jun 14;12(6):1772. doi: 10.3390/nu12061772. Nutrients. 2020. PMID: 32545860 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical